DE60303758D1 - System zur Überwachung des Blutzuckerwerts unter Verwendung einer implantierbaren medizinischen Vorrichtung - Google Patents

System zur Überwachung des Blutzuckerwerts unter Verwendung einer implantierbaren medizinischen Vorrichtung

Info

Publication number
DE60303758D1
DE60303758D1 DE60303758T DE60303758T DE60303758D1 DE 60303758 D1 DE60303758 D1 DE 60303758D1 DE 60303758 T DE60303758 T DE 60303758T DE 60303758 T DE60303758 T DE 60303758T DE 60303758 D1 DE60303758 D1 DE 60303758D1
Authority
DE
Germany
Prior art keywords
medical device
monitoring system
blood glucose
implantable medical
glucose monitoring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60303758T
Other languages
English (en)
Other versions
DE60303758T2 (de
Inventor
Mark W Kroll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pacesetter Inc
Original Assignee
Pacesetter Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pacesetter Inc filed Critical Pacesetter Inc
Application granted granted Critical
Publication of DE60303758D1 publication Critical patent/DE60303758D1/de
Publication of DE60303758T2 publication Critical patent/DE60303758T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • A61B5/355—Detecting T-waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/316—Modalities, i.e. specific diagnostic methods
    • A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
    • A61B5/346—Analysis of electrocardiograms
    • A61B5/349—Detecting specific parameters of the electrocardiograph cycle
    • A61B5/36—Detecting PQ interval, PR interval or QT interval
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/37—Monitoring; Protecting
    • A61N1/3702—Physiological parameters
DE60303758T 2002-10-21 2003-10-20 System zur Überwachung des Blutzuckerwerts unter Verwendung einer implantierbaren medizinischen Vorrichtung Expired - Lifetime DE60303758T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US277468 2002-10-21
US10/277,468 US7029443B2 (en) 2002-10-21 2002-10-21 System and method for monitoring blood glucose levels using an implantable medical device
US277467 2002-10-21
US10/277,467 US7016720B2 (en) 2002-10-21 2002-10-21 System and method for monitoring blood glucose levels using an implantable medical device

Publications (2)

Publication Number Publication Date
DE60303758D1 true DE60303758D1 (de) 2006-04-27
DE60303758T2 DE60303758T2 (de) 2006-08-31

Family

ID=32179470

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60303758T Expired - Lifetime DE60303758T2 (de) 2002-10-21 2003-10-20 System zur Überwachung des Blutzuckerwerts unter Verwendung einer implantierbaren medizinischen Vorrichtung

Country Status (3)

Country Link
US (3) US7029443B2 (de)
EP (1) EP1419731B1 (de)
DE (1) DE60303758T2 (de)

Families Citing this family (93)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4498636B2 (ja) 2001-04-27 2010-07-07 日本サーモスタット株式会社 サーモスタット装置
US7103412B1 (en) * 2003-05-02 2006-09-05 Pacesetter, Inc. Implantable cardiac stimulation device and method for detecting asymptomatic diabetes
AU2003902187A0 (en) * 2003-05-08 2003-05-22 Aimedics Pty Ltd Patient monitor
US20050027183A1 (en) * 2003-07-01 2005-02-03 Antonio Sastre Method for non-invasive monitoring of blood and tissue glucose
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US20050033133A1 (en) * 2003-08-06 2005-02-10 Clifford Kraft Implantable chip medical diagnostic device for bodily fluids
WO2006066577A1 (en) * 2004-12-20 2006-06-29 Hyposafe A/S Method and apparatus for prediction and warning of hypoglycaemic attack
US7502644B2 (en) * 2005-01-25 2009-03-10 Pacesetter, Inc. System and method for distinguishing among cardiac ischemia, hypoglycemia and hyperglycemia using an implantable medical device
US7756572B1 (en) 2005-01-25 2010-07-13 Pacesetter, Inc. System and method for efficiently distinguishing among cardiac ischemia, hypoglycemia and hyperglycemia using an implantable medical device and an external system
US7794742B2 (en) * 2005-02-08 2010-09-14 University Of Washington Devices for promoting epithelial cell differentiation and keratinization
US7590443B2 (en) * 2005-04-27 2009-09-15 Pacesetter, Inc System and method for detecting hypoglycemia based on a paced depolarization integral using an implantable medical device
US7904158B2 (en) * 2005-04-28 2011-03-08 Medtronic, Inc. Measurement of coronary sinus parameters to optimize left ventricular performance
US8251904B2 (en) 2005-06-09 2012-08-28 Roche Diagnostics Operations, Inc. Device and method for insulin dosing
US7529580B2 (en) * 2005-08-11 2009-05-05 Pacesetter, Inc. Detection of renal failure by cardiac implantable medical device
US7400920B1 (en) 2005-08-11 2008-07-15 Pacesetter, Inc. Detection of renal failure by cardiac implantable medical device
US20080314395A1 (en) 2005-08-31 2008-12-25 Theuniversity Of Virginia Patent Foundation Accuracy of Continuous Glucose Sensors
US8219173B2 (en) 2008-09-30 2012-07-10 Abbott Diabetes Care Inc. Optimizing analyte sensor calibration
US9392969B2 (en) 2008-08-31 2016-07-19 Abbott Diabetes Care Inc. Closed loop control and signal attenuation detection
US7630748B2 (en) 2006-10-25 2009-12-08 Abbott Diabetes Care Inc. Method and system for providing analyte monitoring
US8224415B2 (en) 2009-01-29 2012-07-17 Abbott Diabetes Care Inc. Method and device for providing offset model based calibration for analyte sensor
US9675290B2 (en) 2012-10-30 2017-06-13 Abbott Diabetes Care Inc. Sensitivity calibration of in vivo sensors used to measure analyte concentration
US7672716B1 (en) 2006-04-03 2010-03-02 Pacesetter, Inc. QT-based system and method for detecting and distinguishing dilated cardiomyopathy and heart failure using an implantable medical device
US7462150B1 (en) 2006-06-09 2008-12-09 Pacesetter, Inc. System and method for evaluating impaired glucose tolerance and diabetes mellitus within a patient using an implantable medical device
EP2106238A4 (de) 2006-10-26 2011-03-09 Abbott Diabetes Care Inc Verfahren, system und computerprogrammprodukt zur echtzeit-erkennung eines empfindlichkeitsabfalls in analytsensoren
US8092386B1 (en) 2006-12-22 2012-01-10 Pacesetter, Inc. Method and implantable system for blood-glucose concentration monitoring
US8934963B1 (en) 2007-01-16 2015-01-13 Pacesetter, Inc. Method and apparatus for monitoring arrythmogenic effects of medications using an implantable device
US8265739B1 (en) 2007-01-19 2012-09-11 Pacesetter, Inc. Systems and methods for distinguishing cardiac ischemia from systemic influences on IEGM morphology using an implantable medical device
US8417311B2 (en) * 2008-09-12 2013-04-09 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US7769436B1 (en) 2007-06-04 2010-08-03 Pacesetter, Inc. System and method for adaptively adjusting cardiac ischemia detection thresholds and other detection thresholds used by an implantable medical device
US7731658B2 (en) * 2007-08-16 2010-06-08 Cardiac Pacemakers, Inc. Glycemic control monitoring using implantable medical device
US7813791B1 (en) 2007-08-20 2010-10-12 Pacesetter, Inc. Systems and methods for employing an FFT to distinguish R-waves from T-waves using an implantable medical device
US8019410B1 (en) 2007-08-22 2011-09-13 Pacesetter, Inc. System and method for detecting hypoglycemia using an implantable medical device based on pre-symptomatic physiological responses
CA3105353A1 (en) 2007-10-10 2009-04-16 Optiscan Biomedical Corporation Fluid component analysis system and method for glucose monitoring and control
US8216138B1 (en) 2007-10-23 2012-07-10 Abbott Diabetes Care Inc. Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration
US20090137890A1 (en) * 2007-11-27 2009-05-28 Burnes John E Devices to monitor glucose levels and ischemia
US20090164239A1 (en) 2007-12-19 2009-06-25 Abbott Diabetes Care, Inc. Dynamic Display Of Glucose Information
US7959598B2 (en) 2008-08-20 2011-06-14 Asante Solutions, Inc. Infusion pump systems and methods
US20100057158A1 (en) * 2008-08-26 2010-03-04 Pacesetter, Inc. Neurostimulation Based On Glycemic Condition
US9301698B2 (en) 2008-10-31 2016-04-05 Medtronic, Inc. Method and apparatus to detect ischemia with a pressure sensor
US9326707B2 (en) 2008-11-10 2016-05-03 Abbott Diabetes Care Inc. Alarm characterization for analyte monitoring devices and systems
US8280523B2 (en) 2008-12-22 2012-10-02 Pacesetter, Inc. System and method for monitoring diastolic function using an implantable medical device
JP2012513626A (ja) 2008-12-23 2012-06-14 エフ．ホフマン−ラ ロシュ アーゲー 収集装置で作動する構造化収集手続の実装、実行、データ収集、及びデータ分析のための管理方法及びシステム
US9918635B2 (en) 2008-12-23 2018-03-20 Roche Diabetes Care, Inc. Systems and methods for optimizing insulin dosage
US20120011125A1 (en) 2008-12-23 2012-01-12 Roche Diagnostics Operations, Inc. Management method and system for implementation, execution, data collection, and data analysis of a structured collection procedure which runs on a collection device
US10437962B2 (en) 2008-12-23 2019-10-08 Roche Diabetes Care Inc Status reporting of a structured collection procedure
US10456036B2 (en) 2008-12-23 2019-10-29 Roche Diabetes Care, Inc. Structured tailoring
BRPI1008849B8 (pt) * 2009-02-04 2021-06-22 Sanofi Aventis Deutschland dispositivo médico e método para controle glicêmico
US8630692B2 (en) 2009-04-30 2014-01-14 Pacesetter, Inc. Method and implantable system for blood-glucose concentration monitoring using parallel methodologies
WO2010121229A1 (en) 2009-04-16 2010-10-21 Abbott Diabetes Care Inc. Analyte sensor calibration management
WO2011053881A1 (en) 2009-10-30 2011-05-05 Abbott Diabetes Care Inc. Method and apparatus for detecting false hypoglycemic conditions
AU2010314811A1 (en) * 2009-11-04 2012-06-21 Aimedics Pty Ltd Alarm systems using monitored physiological data and trend difference methods
JP2013509278A (ja) * 2009-11-04 2013-03-14 アイメディックス ピーティーワイ リミテッド 融合データ低血糖警告を閉ループ血糖管理システムに組み込むためのシステム及び方法
WO2011112753A1 (en) 2010-03-10 2011-09-15 Abbott Diabetes Care Inc. Systems, devices and methods for managing glucose levels
US8635046B2 (en) 2010-06-23 2014-01-21 Abbott Diabetes Care Inc. Method and system for evaluating analyte sensor response characteristics
US10092229B2 (en) 2010-06-29 2018-10-09 Abbott Diabetes Care Inc. Calibration of analyte measurement system
US20120173151A1 (en) 2010-12-29 2012-07-05 Roche Diagnostics Operations, Inc. Methods of assessing diabetes treatment protocols based on protocol complexity levels and patient proficiency levels
DK3575796T3 (da) 2011-04-15 2021-01-18 Dexcom Inc Avanceret analytsensorkalibrering og fejldetektion
US9158890B2 (en) 2011-07-27 2015-10-13 At&T Mobility Ii Llc Mobile applications and methods for conveying performance information of a cardiac pacemaker
WO2013066849A1 (en) 2011-10-31 2013-05-10 Abbott Diabetes Care Inc. Model based variable risk false glucose threshold alarm prevention mechanism
CN102500013A (zh) * 2011-11-22 2012-06-20 北京化工大学 基于模型预测控制的大剂量胰岛素全自动智能输注方法和装置
EP2825096B1 (de) 2012-03-16 2023-04-26 Dexcom, Inc. Systeme und verfahren zur verarbeitung von analytsensordaten
US20130332196A1 (en) * 2012-06-07 2013-12-12 The Government Of The United States As Represented By The Secretary Of The Army Diabetes Monitoring Using Smart Device
EP2898470A4 (de) * 2012-09-21 2017-09-06 CardioMems, Inc. Verfahren und system für trendbasiertes patientenmanagement
US9907492B2 (en) 2012-09-26 2018-03-06 Abbott Diabetes Care Inc. Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data
EP2770452A1 (de) * 2013-02-22 2014-08-27 Samsung Electronics Co., Ltd. Verfahren und System zur Übertragung des Ergebnisses einer Probenanalyse aus einer medizinischen Vorrichtung über eine mobile Vorrichtung an das Ziel
US10404784B2 (en) * 2013-02-22 2019-09-03 Samsung Electronics Co., Ltd. Method and system for transmitting result of examination of specimen from medical device to destination
US9474475B1 (en) 2013-03-15 2016-10-25 Abbott Diabetes Care Inc. Multi-rate analyte sensor data collection with sample rate configurable signal processing
WO2014152034A1 (en) 2013-03-15 2014-09-25 Abbott Diabetes Care Inc. Sensor fault detection using analyte sensor data pattern comparison
US10433773B1 (en) 2013-03-15 2019-10-08 Abbott Diabetes Care Inc. Noise rejection methods and apparatus for sparsely sampled analyte sensor data
GB2523989B (en) 2014-01-30 2020-07-29 Insulet Netherlands B V Therapeutic product delivery system and method of pairing
EP4151150A1 (de) 2014-03-30 2023-03-22 Abbott Diabetes Care, Inc. Verfahren und gerät zum bestimmen von mahlzeitenbeginn und peak-ereignissen in analytischen überwachungssystemen
US10737024B2 (en) 2015-02-18 2020-08-11 Insulet Corporation Fluid delivery and infusion devices, and methods of use thereof
WO2017123525A1 (en) 2016-01-13 2017-07-20 Bigfoot Biomedical, Inc. User interface for diabetes management system
EP3453414A1 (de) 2016-01-14 2019-03-13 Bigfoot Biomedical, Inc. Anpassung von insulinabgaberaten
US11657175B2 (en) * 2016-02-23 2023-05-23 Philips Medical Systems Technologies Ltd Patient medical data acquisition system and method using an external device
EP3515535A1 (de) 2016-09-23 2019-07-31 Insulet Corporation Flüssigkeitsabgabevorrichtung mit sensor
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US20190120785A1 (en) 2017-10-24 2019-04-25 Dexcom, Inc. Pre-connected analyte sensors
USD928199S1 (en) 2018-04-02 2021-08-17 Bigfoot Biomedical, Inc. Medication delivery device with icons
CN112236826A (zh) 2018-05-04 2021-01-15 英赛罗公司 基于控制算法的药物输送系统的安全约束
CA3112209C (en) 2018-09-28 2023-08-29 Insulet Corporation Activity mode for artificial pancreas system
US11565039B2 (en) 2018-10-11 2023-01-31 Insulet Corporation Event detection for drug delivery system
US11801344B2 (en) 2019-09-13 2023-10-31 Insulet Corporation Blood glucose rate of change modulation of meal and correction insulin bolus quantity
US11935637B2 (en) 2019-09-27 2024-03-19 Insulet Corporation Onboarding and total daily insulin adaptivity
US11833329B2 (en) 2019-12-20 2023-12-05 Insulet Corporation Techniques for improved automatic drug delivery performance using delivery tendencies from past delivery history and use patterns
US11551802B2 (en) 2020-02-11 2023-01-10 Insulet Corporation Early meal detection and calorie intake detection
US11547800B2 (en) 2020-02-12 2023-01-10 Insulet Corporation User parameter dependent cost function for personalized reduction of hypoglycemia and/or hyperglycemia in a closed loop artificial pancreas system
US11324889B2 (en) 2020-02-14 2022-05-10 Insulet Corporation Compensation for missing readings from a glucose monitor in an automated insulin delivery system
US11607493B2 (en) 2020-04-06 2023-03-21 Insulet Corporation Initial total daily insulin setting for user onboarding
US11684716B2 (en) 2020-07-31 2023-06-27 Insulet Corporation Techniques to reduce risk of occlusions in drug delivery systems
US11904140B2 (en) 2021-03-10 2024-02-20 Insulet Corporation Adaptable asymmetric medicament cost component in a control system for medicament delivery
WO2023049900A1 (en) 2021-09-27 2023-03-30 Insulet Corporation Techniques enabling adaptation of parameters in aid systems by user input
US11439754B1 (en) 2021-12-01 2022-09-13 Insulet Corporation Optimizing embedded formulations for drug delivery

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4731051A (en) 1979-04-27 1988-03-15 The Johns Hopkins University Programmable control means for providing safe and controlled medication infusion
NL8105381A (nl) * 1981-11-27 1983-06-16 Tno Werkwijze en inrichting voor het corrigeren van de manchetdruk bij het meten van de bloeddruk in een lichaamsdeel met behulp van een plethysmograaf.
US4704029A (en) * 1985-12-26 1987-11-03 Research Corporation Blood glucose monitor
US4947845A (en) * 1989-01-13 1990-08-14 Pacesetter Infusion, Ltd. Method of maximizing catheter longevity in an implantable medication infusion system
US5437285A (en) * 1991-02-20 1995-08-01 Georgetown University Method and apparatus for prediction of sudden cardiac death by simultaneous assessment of autonomic function and cardiac electrical stability
US5272379A (en) * 1991-09-26 1993-12-21 Mitsubishi Denki K.K. Power supply device for an electric vehicle
US5419338A (en) * 1994-02-22 1995-05-30 City Of Hope Autonomic nervous system testing by bi-variate spectral analysis of heart period and QT interval variability
US5741211A (en) 1995-10-26 1998-04-21 Medtronic, Inc. System and method for continuous monitoring of diabetes-related blood constituents
US5919216A (en) 1997-06-16 1999-07-06 Medtronic, Inc. System and method for enhancement of glucose production by stimulation of pancreatic beta cells
US6353226B1 (en) * 1998-11-23 2002-03-05 Abbott Laboratories Non-invasive sensor capable of determining optical parameters in a sample having multiple layers
US6272379B1 (en) 1999-03-17 2001-08-07 Cathco, Inc. Implantable electronic system with acute myocardial infarction detection and patient warning capabilities
US6923763B1 (en) * 1999-08-23 2005-08-02 University Of Virginia Patent Foundation Method and apparatus for predicting the risk of hypoglycemia
US20020026141A1 (en) 1999-11-04 2002-02-28 Medtronic, Inc. System for pancreatic stimulation and glucose measurement
US6572542B1 (en) 2000-03-03 2003-06-03 Medtronic, Inc. System and method for monitoring and controlling the glycemic state of a patient
AUPR343401A0 (en) * 2001-02-28 2001-03-29 Nguyen, Hung Modelling and design for early warning systems using physiological responses
US7069078B2 (en) * 2002-04-22 2006-06-27 Medtronic, Inc. Insulin-mediated glucose uptake monitor

Also Published As

Publication number Publication date
EP1419731B1 (de) 2006-03-01
US7016720B2 (en) 2006-03-21
US7680529B2 (en) 2010-03-16
US20040077962A1 (en) 2004-04-22
DE60303758T2 (de) 2006-08-31
US7029443B2 (en) 2006-04-18
US20060100494A1 (en) 2006-05-11
EP1419731A1 (de) 2004-05-19
US20040078065A1 (en) 2004-04-22

Similar Documents

Publication Publication Date Title
DE60303758D1 (de) System zur Überwachung des Blutzuckerwerts unter Verwendung einer implantierbaren medizinischen Vorrichtung
DE60118433D1 (de) Implantierbare medizinische vorrichtung zur überwachung von kongestiver herzinsuffizienz
DE50301751D1 (de) Vorrichtung zur überwachung medizinischer geräte
DE19927853B8 (de) System zur Kommunikation mit einer implantierten medizinischen Vorrichtung
DE60319223D1 (de) Vorrichtung zur verhütung von arrhythmie-häufungen unter verwendung von schnellgang-impulsgebung
DE602004026552D1 (de) Verfahren, vorrichtung und system zur kommunikation mit medizinischen geräten
DE60317358D1 (de) System zur Positionierung einer medizinischen Vorrichtung
DE60114228D1 (de) Vorrichtung zur glukoseüberwachung mit netzwerkanschluss
DE602004009171D1 (de) Methode und vorrichtung zur verbesserung des ventrikulären status unter verwendung der kraft-intervall-beziehung
DE60329729D1 (de) Implantierbare Vorrichtung zur Arzneimittelverabreichung
DE60330632D1 (de) Vorrichtung zur Überwachung des Herzens
DE69934219D1 (de) Vorrichtung zur blutanalyse
ATE317678T1 (de) Vorrichtung zur zufuhr von flüssigkeit für ein augenchirurgisches handstück
AU2003238270A1 (en) Method and system for monitoring patient care
DK1385423T3 (da) Udstyr til måling af glukosekoncentrationer i blod
DE602005001342D1 (de) System zur elektrischen Therapie während Hyperventilationsphasen einer periodischen Atmung unter Verwendung einer implantierbaren medizinischen Einrichtung
HK1096566A1 (en) Implantable biosensor devices for monitoring cardiac marker molecules
AU2003295987A1 (en) System and method for automatic diagnosis of patient health
EP1671594A4 (de) Medizinische klammervorrichtung, medizinisches instrument und verfahren zum schneiden von gewebe eines organismus mit der vorrichtung
ATE534430T1 (de) Implantierbarer herzstimulator, vorrichtung und system zur überwachung des status einer herzleitung
DE60301161D1 (de) Vorrichtung zur Überwachung des Herzens und ein System beinhaltend eine solche Vorrichtung
DE60302089D1 (de) Vorrichtung zur Überwachung des Herzens
WO2005072218A3 (en) Bone fixation system and method
DE60327533D1 (de) Vorrichtung zur transcervicalen sterilisierung unter verwendung von ultraschall
DE502004010500D1 (de) Vorrichtung zur koagulation von gewebe

Legal Events

Date Code Title Description
8364 No opposition during term of opposition